Latest News about ASND

Recent news which mentions ASND

< Previous 1 2 3 4 5 6 Next >

Ascendis Seeks FDA Nod For TransCon PTH In Adults With Hypoparathyroidism

August 31, 2022

Expert Ratings for Ascendis Pharma

August 30, 2022

Oppenheimer Maintains Outperform Rating for Ascendis Pharma: Here's What You Need To Know

August 11, 2022

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial

August 10, 2022

What 14 Analyst Ratings Have To Say About Ascendis Pharma

May 12, 2022

Why Ascendis Pharma Stock Is Sinking Today

May 12, 2022

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

March 24, 2022

BofA Upgrades Ascendis Pharma After Promising TCP Phase 3 Data

March 15, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022

March 15, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session

March 14, 2022

10 Biggest Price Target Changes For Monday

March 14, 2022

Ascendis Pharma's Hypoparathyroidism Trial Meets Primary, Secondary Endpoints

March 14, 2022

7 Biotech Stocks With Key Catalysts in March

March 09, 2022

Expert Ratings For Ascendis Pharma

March 07, 2022

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO

March 03, 2022

Earnings Scheduled For March 2, 2022

March 02, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022

March 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022

February 14, 2022

Where Ascendis Pharma Stands With Analysts

January 27, 2022

Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval

January 13, 2022

Where Ascendis Pharma Stands With Analysts

January 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022

January 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021

December 08, 2021

The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial

November 19, 2021

Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks

November 19, 2021

10 Biggest Price Target Changes For Monday

November 15, 2021

Analyst Ratings For Ascendis Pharma

November 11, 2021

Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript

November 10, 2021

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021

October 20, 2021

This Growth Hormone Drug Could Be a Boost For Pfizer

October 05, 2021

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.